A small molecule that inhibits a protein important for chromatin organization can cause reversible sterility in male mice.
The Scientist
Most Recent
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.
Researchers track tumors as they develop, providing more support for the idea that cells with stem-cell-like properties underlie cancer growth and recurrence.
Lymphatic vessels grow towards two chemokines, revealing signals that could be important in cancer metastasis.
A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.
The National Institutes of Health will fund 17 projects developing lab-on-a-chip applications to improve drug screening.
An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.
After years of complaints, the European Commission proposes ways to fix its system in an effort to reinvigorate research on the continent.
A new study suggests that a drug for blood poisoning that was withdrawn by its manufacturer does work after all.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
